nodes	percent_of_prediction	percent_of_DWPC	metapath
Propylhexedrine—TAAR1—Amine ligand-binding receptors—ADRA1D—polycystic ovary syndrome	0.0633	0.0633	CbGpPWpGaD
Propylhexedrine—TAAR1—Amine ligand-binding receptors—ADRA1B—polycystic ovary syndrome	0.0615	0.0615	CbGpPWpGaD
Propylhexedrine—TAAR1—Amine ligand-binding receptors—ADRA1A—polycystic ovary syndrome	0.0466	0.0466	CbGpPWpGaD
Propylhexedrine—TAAR1—Amine ligand-binding receptors—ADRB3—polycystic ovary syndrome	0.0449	0.0449	CbGpPWpGaD
Propylhexedrine—TAAR1—G alpha (s) signalling events—LHCGR—polycystic ovary syndrome	0.0287	0.0287	CbGpPWpGaD
Propylhexedrine—TAAR1—Amine ligand-binding receptors—ADRB2—polycystic ovary syndrome	0.0242	0.0242	CbGpPWpGaD
Propylhexedrine—TAAR1—G alpha (s) signalling events—PDE3B—polycystic ovary syndrome	0.0231	0.0231	CbGpPWpGaD
Propylhexedrine—SLC18A2—Nicotine Activity on Dopaminergic Neurons—TH—polycystic ovary syndrome	0.0229	0.0229	CbGpPWpGaD
Propylhexedrine—TAAR1—G alpha (s) signalling events—FSHR—polycystic ovary syndrome	0.021	0.021	CbGpPWpGaD
Propylhexedrine—TAAR1—G alpha (s) signalling events—ADRB3—polycystic ovary syndrome	0.0185	0.0185	CbGpPWpGaD
Propylhexedrine—TAAR1—G alpha (s) signalling events—LHB—polycystic ovary syndrome	0.0183	0.0183	CbGpPWpGaD
Propylhexedrine—SLC18A2—Dopaminergic Neurogenesis—TH—polycystic ovary syndrome	0.0172	0.0172	CbGpPWpGaD
Propylhexedrine—TAAR1—G alpha (s) signalling events—SCT—polycystic ovary syndrome	0.0171	0.0171	CbGpPWpGaD
Propylhexedrine—TAAR1—Class A/1 (Rhodopsin-like receptors)—NPB—polycystic ovary syndrome	0.0164	0.0164	CbGpPWpGaD
Propylhexedrine—TAAR1—Class A/1 (Rhodopsin-like receptors)—PTGER3—polycystic ovary syndrome	0.0137	0.0137	CbGpPWpGaD
Propylhexedrine—TAAR1—Class A/1 (Rhodopsin-like receptors)—LHCGR—polycystic ovary syndrome	0.0137	0.0137	CbGpPWpGaD
Propylhexedrine—TAAR1—Class A/1 (Rhodopsin-like receptors)—PTAFR—polycystic ovary syndrome	0.0128	0.0128	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR ligand binding—NPB—polycystic ovary syndrome	0.0125	0.0125	CbGpPWpGaD
Propylhexedrine—TAAR1—Class A/1 (Rhodopsin-like receptors)—ADRA1D—polycystic ovary syndrome	0.0124	0.0124	CbGpPWpGaD
Propylhexedrine—TAAR1—Class A/1 (Rhodopsin-like receptors)—ADRA1B—polycystic ovary syndrome	0.0121	0.0121	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.0104	0.0104	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.0104	0.0104	CbGpPWpGaD
Propylhexedrine—TAAR1—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.01	0.01	CbGpPWpGaD
Propylhexedrine—TAAR1—G alpha (s) signalling events—ADRB2—polycystic ovary syndrome	0.01	0.01	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.00976	0.00976	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.00947	0.00947	CbGpPWpGaD
Propylhexedrine—TAAR1—G alpha (s) signalling events—GNAS—polycystic ovary syndrome	0.00927	0.00927	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.00922	0.00922	CbGpPWpGaD
Propylhexedrine—TAAR1—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.00917	0.00917	CbGpPWpGaD
Propylhexedrine—TAAR1—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.00883	0.00883	CbGpPWpGaD
Propylhexedrine—TAAR1—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.00872	0.00872	CbGpPWpGaD
Propylhexedrine—TAAR1—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.00853	0.00853	CbGpPWpGaD
Propylhexedrine—TAAR1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.0078	0.0078	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.00764	0.00764	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.00707	0.00707	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.00699	0.00699	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.00672	0.00672	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR ligand binding—LHB—polycystic ovary syndrome	0.00664	0.00664	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.00662	0.00662	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—polycystic ovary syndrome	0.00655	0.00655	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.00649	0.00649	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—NPB—polycystic ovary syndrome	0.00642	0.00642	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.00639	0.00639	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00626	0.00626	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00626	0.00626	CbGpPWpGaD
Propylhexedrine—TAAR1—G alpha (s) signalling events—POMC—polycystic ovary syndrome	0.00624	0.00624	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR ligand binding—SCT—polycystic ovary syndrome	0.00623	0.00623	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.00594	0.00594	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.0059	0.0059	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.0059	0.0059	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.0058	0.0058	CbGpPWpGaD
Propylhexedrine—TAAR1—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.00576	0.00576	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.00552	0.00552	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00535	0.00535	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00535	0.00535	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00535	0.00535	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00521	0.00521	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00501	0.00501	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.00486	0.00486	CbGpPWpGaD
Propylhexedrine—TAAR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.00477	0.00477	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.00474	0.00474	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.00473	0.00473	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00471	0.00471	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.00443	0.00443	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.00439	0.00439	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00434	0.00434	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.00432	0.00432	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.0043	0.0043	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.00426	0.00426	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00395	0.00395	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00392	0.00392	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00392	0.00392	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.0038	0.0038	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—NPB—polycystic ovary syndrome	0.00379	0.00379	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00375	0.00375	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.00367	0.00367	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.00363	0.00363	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.00358	0.00358	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.00352	0.00352	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.00345	0.00345	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.00343	0.00343	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—LHB—polycystic ovary syndrome	0.00341	0.00341	CbGpPWpGaD
Propylhexedrine—SLC18A2—Neuronal System—CAMK2D—polycystic ovary syndrome	0.0034	0.0034	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.00337	0.00337	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.00336	0.00336	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.00333	0.00333	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—SCT—polycystic ovary syndrome	0.0032	0.0032	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.00316	0.00316	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.00316	0.00316	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.00305	0.00305	CbGpPWpGaD
Propylhexedrine—SLC18A2—Neuronal System—DLG4—polycystic ovary syndrome	0.003	0.003	CbGpPWpGaD
Propylhexedrine—SLC18A2—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	0.00298	0.00298	CbGpPWpGaD
Propylhexedrine—TAAR1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.00298	0.00298	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.00296	0.00296	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.00287	0.00287	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.00279	0.00279	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.00272	0.00272	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.00254	0.00254	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.00248	0.00248	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.00232	0.00232	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.00227	0.00227	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.00225	0.00225	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.00218	0.00218	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.00212	0.00212	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—FST—polycystic ovary syndrome	0.00206	0.00206	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.00205	0.00205	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.00204	0.00204	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—LHB—polycystic ovary syndrome	0.00201	0.00201	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.00197	0.00197	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.00191	0.00191	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.0019	0.0019	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—SCT—polycystic ovary syndrome	0.00189	0.00189	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.00186	0.00186	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.0018	0.0018	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.00178	0.00178	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.00177	0.00177	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.00175	0.00175	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.00173	0.00173	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.00165	0.00165	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.00164	0.00164	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.00162	0.00162	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—INSR—polycystic ovary syndrome	0.00154	0.00154	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.00151	0.00151	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.00147	0.00147	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.00144	0.00144	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—PGR—polycystic ovary syndrome	0.00143	0.00143	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.00133	0.00133	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.00133	0.00133	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.00128	0.00128	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.00127	0.00127	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.00127	0.00127	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.00124	0.00124	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.00123	0.00123	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.00117	0.00117	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.00116	0.00116	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—PRL—polycystic ovary syndrome	0.00116	0.00116	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.00112	0.00112	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.0011	0.0011	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.00102	0.00102	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000972	0.000972	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000954	0.000954	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000817	0.000817	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—LEP—polycystic ovary syndrome	0.0008	0.0008	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000714	0.000714	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—POMC—polycystic ovary syndrome	0.000687	0.000687	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—INS—polycystic ovary syndrome	0.000683	0.000683	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000661	0.000661	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000661	0.000661	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000628	0.000628	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000506	0.000506	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000432	0.000432	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—IL6—polycystic ovary syndrome	0.000299	0.000299	CbGpPWpGaD
